A new study reveals that kidney transplant patients exposed to the Epstein-Barr virus (EBV) face a higher risk of developing ...

Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R−) kidneys have an increased ris ...

PTLD develops in approximately 1 in 5 recipients of EBV-positive donor kidneys, a much higher rate than previously thought. Recipients of kidney transplants infected with Epstein-Barr virus (EBV ...

More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious ...

PHILADELPHIA- More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is ...

The Epstein–Barr virus D-positive/R-negative group had up to a 10-fold higher cumulative incidence of post-transplant lymphoproliferative disorder. Patients who receive kidney transplants from ...

Epstein-Barr virus (EBV) lymphoproliferative disease is seen in patients with both congenital and acquired immunodeficiencies. Lymphoproliferative disease has been reported in 1 to 3% of renal ...

program as monotherapy treatment for adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), as well as ...

as monotherapy treatment for adult and pediatric patients two years of age and older with Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD), who have received at ...

Atara on Tuesday announced that the FDA has placed a clinical hold on the company’s investigational new drug applications for the Europe-approved Ebvallo in Epstein-Barr virus positive post ...

FRIDAY, Feb. 14, 2025 (HealthDay News) – Kidney transplants can be lifesaving, but a new study suggests that some recipients ...